Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LISATA THERAPEUTICS, INC. Director's Dealing 2012

Apr 4, 2012

34931_dirs_2012-04-04_b8ee48a6-1f7e-45be-8d47-7ba55d94cd2a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2012-04-02

Reporting Person: Sackner-Bernstein Jonathan (VP Clinical Dev & Reg Affairs)